Author (Years) | Monitored/ Unmonitored | FITT of intervention | Outcomes | Results | |||
---|---|---|---|---|---|---|---|
Frequency | Intensity | Time | Type of exercise | ||||
Q. Xiang (2024)[69] | Unmonitored | 7 days/week for 12 weeks | (2)(3) 2000 steps/day and 60% of maximum heart rate | ー | (1) BCAA orally group (2) Walking group (3) Walking and BCAA orally group | Motor function: Grip strength, Skeletal muscle mass index | Motor function: Grip strength and skeletal muscle mass index showed predominant improvement. No significant differences were observed between groups. |
Liver function: Serological tests | Liver function: No significant differences were observed between groups | ||||||
E. Sobhy (2024)[70] | Unmonitored | 7 days/week for 4 weeks | ー | 20 min | (1) Standard care group (2) Standard care and BCAA orally group (3) Walking and resistance group (4) Walking and resistance and BCAA orally group | Motor function: Thickness of the quadriceps, Grip strength, Short physical performance battery test | Motor function: Thickness of the quadriceps, grip strength, and short physical performance battery test showed predominant improvement. No significant differences were observed between groups. |
Liver function: MELD, Blood tests, Serological tests | Liver function: MELD showed predominant improvement. No significant differences were observed between groups. | ||||||
L. Skladany( 2024)[71] | Monitored | 3 days/week for 12 weeks | ー | 15–20 min | (1) Walking and resistance group (2) Life guidance group | Motor function: LFI | Motor function: LFI showed predominant improvement in the exercise group. No significant differences were observed between groups. |
Liver function: CP, MELD, Ascites classification | Liver function: Liver function parameters were not significantly different within and between groups. | ||||||
Quality of life: EQ-5D | Quality of life: Quality of life measures were not significantly different within and between groups. | ||||||
E. Román (2024)[66] | Unmonitored | 3 days/week for 12 months | ー | 20–60 min | (1) Cycle ergometry and resistance group (2) Usual care only group | Motor function: LFI, TUG, Gait speed, Body composition test | Motor function: The intervention group showed improvements in LFI, TUG, and gait speed, with significant differences between groups. |
Liver function: Blood tests, Serological tests | Liver function: C-reactive protein decreased in the intervention group compared to the control group. | ||||||
Quality of life: SF-36 | Quality of life: The intervention group showed significant improvements in SF-36 physical function and physical role pre- and post-intervention. | ||||||
P. Sirisunhirun (2022)[46] | Unmonitored | 4 days/week for 12 weeks | (1) 60–80% of heart rate | 40 min | (1) Walking and resistance group (2) Life guidance group | Motor function: 6MD, Thigh muscle mass, Anthropometric measurements | Motor function: No significant differences were observed within and between groups. |
Liver function: Blood tests, Transient elastography(liver and spleen stiffness), CP, MELD | Liver function: LS was significantly different within each group, but no statistically significant differences were found between the two groups. | ||||||
Quality of life: CLDQ | Quality of life: The home-based exercise training group showed significant improvement in CLDQ pre- and post-intervention, but no significant differences were found between groups. | ||||||
D. Rossi (2022)[72] | Monitored | 2 days/week for 12 weeks | (1) Borg Scale 12–14 | 30–50 min | (1) Walking(treadmill) group (2) Home exercise group | Motor function: FSS, Pimax, Pemax, Knee extensor strength, 6MD | Motor function: FSS, Pimax, Pemax, knee extensor strength, and 6MD showed significant differences within and between groups. |
Quality of life: SF-36 | Quality of life: SF-36 showed significant differences within and between groups. | ||||||
S. Mohta (2022)[73] | Unmonitored | 7 days/week for 24 weeks | ー | 30–45 min | (1) Walking and resistance and BCAA orally group (2) Walking and resistance group | Motor function: 6MD, Gait speed, Lower limb strength, Body composition test | Motor Function: No significant differences were observed within and between groups. |
Liver function: Blood tests, Serological tests, Ammonia levels, Serum myostatin levels, MELD | Liver function: No significant differences were observed within and between groups. | ||||||
Quality of life: CLDQ | Quality of life: CLDQ was not significantly different within and between groups. | ||||||
J. C. Lai (2021)[35] | Unmonitored | 3 days/week for 12 weeks | (1) Resistance training sets the load by the type of band. | 30Â min | (1) Walking and resistance group (2) Motor guidance group | Motor function: LFI | Motor Function: LFI was not significantly different within and between groups. |
Quality of life: CLDQ | Quality of life: CLDQ was not significantly different within and between groups. | ||||||
M. Hernández-Conde (2021)[74] | Unmonitored | 3 days/week for 12 weeks | 5,000 to 10,000 steps a day | 30 min | (1) Walking and resistance and BCAA orally exercise and nutrition group (2) Walking and resistance group | Motor function: LFI, Body composition test | Motor function: LFI showed significant differences within and between groups. |
Liver function: Blood tests, Serological tests | Liver function: No significant differences were observed within and between groups. | ||||||
C. M. Morkane (2020)[75] | Monitored | 5 days/week for 6 weeks | 80% of work rate at VOâ‚‚ at AT (moderate) and 50% of the difference between VOâ‚‚ peak and VOâ‚‚ at AT (severe) | 40Â min | (1) Cycle ergometry exercise group (2) Usual care only group | Motor function: CPET | Motor function: The exercise group showed improvement in peak VOâ‚‚. |
H. W. Chen (2020)[76] | Unmonitored | 5 days/week for 12 weeks | (1) Walking adds 500 steps to the normal number of steps each week. | 30Â min | (1) Walking and resistance group (2) Dietary intervention group | Motor function: 6MD, CPET, Body composition test | Motor function: 6MD showed significant differences within and between groups. |
Quality of life: Sickness impact profile (SIP) | Quality of life: The exercise group showed significant improvement in the SIP questionnaire’s ambulation and eating sections pre- and post-intervention. | ||||||
L. Aamann (2020)[31] | Monitored | 36 trials for 12 weeks | (1) Load capacity to perform 15 cycles at moderate intensity. | ー | (1) Resistance exercise group (2) Relaxation program group | Motor function: Isokinetic knee extension peak torque, Cross-sectional area [CSA] of the quadriceps muscle, Body composition test, 6MD | Motor function: The exercise group showed significant improvement in isokinetic knee extension peak torque and CSA within and between groups. The exercise group also showed significant improvement in 6MD pre- and post-intervention. |
Liver function: Blood tests, MELD, Ammonia Metabolism/Glutamine Challenge | Liver function: No significant differences were observed within and between groups. | ||||||
Quality of life: SF-36 | Quality of life: The exercise group showed significant improvements in SF-36 vitality and mental health pre- and post-intervention. | ||||||
C. Kruger (2018)[36] | Unmonitored | 3 days/week for 8 weeks | ー | ー | (1) Cycle ergometry   exercise group (2) Usual care only group | Motor function: peak VO2, 6MD | Motor function: The exercise group showed significant improvement in peak VO₂ pre- and post-intervention. 6MD showed significant differences between groups. |
Liver function: Blood tests, MELD | Liver function: No significant differences were observed within and between groups. | ||||||
Quality of life: CLDQ, EQ-VAS | Quality of life: CLDQ and EQ-VAS showed no significant differences within and between groups. | ||||||
A. Hiraoka (2017)[77] | Unmonitored | 7 days/week for 12 weeks | (1) The normal number of steps plus 2000 steps | ー | (1) Walking group | Motor function: Body composition test, Lower limb strength, Grip strength | Motor function: Motor function showed predominant improvement pre- and post-intervention. |
Liver function: Serological tests | Liver function: No changes were observed pre- and post-intervention. | ||||||
A. Berzigotti (2016)[79] | Monitored | 1 days/week for 16 weeks | (1) Borg Scale 10–12 | 60 min | (1) Aerobic and resistance group | Motor function: Maximal oxygen uptake | Motor function: The exercise group showed improvement in maximal oxygen uptake. |
Liver function: Blood tests, Serological tests | Liver function: No changes were observed pre- and post-intervention. | ||||||
Quality of life: CLDQ | Quality of life: The exercise group showed improvement in CLDQ. | ||||||
E. Román (2016)[11] | Monitored | 3 days/week for 12 weeks | ー | 60 min | (1) Cycle ergometry and resistance exercise group (2) Usual care only group | Motor function: TUG, CPET, Body composition test | Motor function: TUG showed predominant improvement pre- and post-intervention. No significant differences were observed between groups. |
L. Zenith (2014)[12] | Monitored | 3 days/week for 8 weeks | (1) 60–70% of maximum heart rate | 30 min | (1) Cycle ergometry exercise group (2) Motor guidance group | Motor function: Peak VO2, Muscle mass and thigh circumference, 6MD | Motor function: Peak VO₂ and 6MD showed significant differences within and between groups. |
Liver function: Blood tests, Serological tests, MELD, CP | Liver function: No significant differences were observed within and between groups. | ||||||
Quality of life: CLDQ, EQ-VAS | Quality of life: The activity and fatigue subscores of the CLDQ and EQ-VAS showed significant differences within and between groups. | ||||||
E. Román (2014)[79] | Monitored | 3 days/week for 12 weeks | (1) 60% of maximum heart rate | ー | (1) Cycle ergometry & Walking   Exercise group (2) Nutrition guidance   Control group | Motor function: 6MD, 2-minute step test | Motor function: 6MD and the 2-minute step test showed predominant improvement pre- and post-intervention. No significant differences were observed between groups. |
Liver function: Blood tests, Serological tests, MELD, CP | Liver function: No significant differences were observed within and between groups. | ||||||
Quality of life: SF-36 | Quality of life: The general health, vitality, and social function subscores of SF-36 showed significant differences within and between groups. |